Abstract
A 3-step glioblastoma-tropic delivery and therapy method using nanoparticle programmed self-destructive neural stem cells (NSCs) is demonstrated in vivo: 1) FDA-approved NSCs for clinical trials are loaded with pH-sensitive MSN-Dox; 2) the nanoparticle conjugates provide a delayed drug-releasing mechanism and allow for NSC migration towards a distant tumor site; 3) NSCs eventually undergo cell death and release impregnated MSN-Dox, which subsequently induces toxicity towards surrounding glioma cells.
Original language | English (US) |
---|---|
Pages (from-to) | 4123-4129 |
Number of pages | 7 |
Journal | Small |
Volume | 9 |
Issue number | 24 |
DOIs | |
State | Published - Dec 20 2013 |
Keywords
- doxorubicin
- drug delivery
- glioblastoma
- glioma
- mesoporous silica nanoparticles
- neural stem cells
- targeted delivery
ASJC Scopus subject areas
- Biotechnology
- Biomaterials
- Chemistry(all)
- Materials Science(all)